This inventor holds 4 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignees: Enyo Pharma, Abbvie Inc., Laboratoires Fournier Sa. Active years: 2013-2023.
Company Filing History:
2 out of 8 
1 out of 826 
1 out of 20 Years Active: 2013-2023
Title: Fabrice Guillier: Innovator in Antiviral Compounds
Introduction
Fabrice Guillier is a notable inventor based in Belleneuve, France. He has made significant contributions to the field of antiviral agents, holding a total of four patents. His work focuses on developing new classes of compounds that exhibit antiviral effects.
Latest Patents
Among his latest patents are the "Thiophene derivatives as antiviral agents." This invention relates to a new class of compounds that have demonstrated antiviral properties. The compounds are characterized by a specific formula and are intended for various uses in combating viral infections.
Career Highlights
Fabrice has worked with prominent companies in the pharmaceutical industry, including Enyo Pharma and AbbVie Inc. His experience in these organizations has allowed him to advance his research and development efforts in antiviral therapies.
Collaborations
Fabrice has collaborated with several professionals in his field, including Benaissa Boubia and Eric Meldrum. These partnerships have contributed to the success of his projects and the advancement of his inventions.
Conclusion
Fabrice Guillier is a dedicated inventor whose work in antiviral compounds has the potential to make a significant impact in the medical field. His innovative approach and collaborations highlight his commitment to advancing healthcare solutions.